These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2016-004459-65 Reslizumab in patients with severe asthma who failed to respond to omalizumab: a pilot study Estudio piloto de reslizumab en pacientes con asma grave que no han respondido a omalizumab not-yet-due